Chromosome 16q Loss in Prostate Cancer
Author Information
Author(s): Elo J P, Härkönen P, Kyllönen A P, Lukkarinen O, Vihko P
Primary Institution: Biocenter Oulu and WHO Collaborating Centre for Research on Reproductive Health, University of Oulu
Hypothesis
Loss of heterozygosity at chromosome arm 16q is associated with aggressive behavior and poor prognosis in prostate cancer.
Conclusion
The study found that allelic losses at specific regions of chromosome 16q are linked to aggressive prostate cancer and lower survival rates.
Supporting Evidence
- Loss of heterozygosity at chromosome 16q is common in prostate cancer.
- Patients with allelic loss at 16q24.1–q24.2 had a 45% rate of distant metastasis during follow-up.
- 32% of patients remained alive after 5 years, while 43% died from prostate cancer.
Takeaway
If a part of a chromosome is missing in prostate cancer patients, it can mean the cancer is more aggressive and harder to treat.
Methodology
The study used 15 PCR markers to analyze loss of heterozygosity in prostate cancer patients and compared findings with clinical features and survival rates.
Participant Demographics
Prostate cancer patients with various clinical features.
Statistical Information
P-Value
P<0.01, P<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website